[en] Several ethical aspects in the management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) are still controversial, including family planning and testing for disease presence in at-risk individuals. We performed an online survey aiming to assess the opinion and current clinical practice of European pediatric and adult nephrologists, as well as geneticists. A total of 410 clinicians (53% male, mean (SD) age of 48 (10) years) responded, including 216 pediatric nephrologists, 151 adult nephrologists, and 43 clinical geneticists. While the 3 groups agreed to encourage clinical testing in asymptomatic ADPKD minors and adults, only geneticists would recommend genetic testing in asymptomatic at-risk adults (P<0.001). Statistically significant disagreement between disciplines was observed regarding the ethical justification of prenatal genetic diagnosis, termination of pregnancy and pre-implantation genetic diagnosis (PGD) for ADPKD. Particularly, PGD is ethically justified according to geneticists (4.48 (1.63)), whereas pediatric (3.08 (1.78); P<0.001) and adult nephrologists (3.66 (1.88); P<0.05) appeared to be less convinced. Our survey suggests that most clinicians support clinical testing of at-risk minors and adults in ADPKD families. However, there is no agreement for genetic testing in asymptomatic offspring and for family planning, including PGD. The present data highlight the need for a consensus among clinicians, to avoid that ADPKD families are being given conflicting information.
Disciplines :
Urology & nephrology
Author, co-author :
De Rechter, Stephanie
Kringen, Jonathan
Janssens, Peter
Liebau, Max Christoph
Devriendt, Koenraad
Levtchenko, Elena
Bergmann, Carsten
Jouret, François ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Bammens, Bert
Borry, Pascal
Schaefer, Franz
Mekahli, Djalila
Language :
English
Title :
Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.
Publication date :
2017
Journal title :
PLoS ONE
eISSN :
1932-6203
Publisher :
Public Library of Science, United States - California
Chebib FT, Torres VE. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2016; 67(5):792–810. Epub 2015/11/05. https://doi.org/10.1053/j.ajkd.2015.07.037 PMID: 26530876; PubMed Central PMCID: PMCPMC4837006.
Dalgaard OZ. Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta medica Scandinavica Supplementum. 1957; 328:1–255. Epub 1957/01/01. PMID: 13469269.
Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. The New England journal of medicine. 2008; 359(14):1477–85. Epub 2008/10/04. https://doi.org/10.1056/NEJMcp0804458 PMID: 18832246.
Reddy BV, Chapman AB. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatric nephrology (Berlin, Germany). 2016; 32(1):31–42. Epub 2016/04/02. https://doi.org/10.1007/s00467-016-3364-y PMID: 27034070.
Grantham JJ, Cook LT, Wetzel LH, Cadnapaphornchai MA, Bae KT. Evidence of extraordinary growth in the progressive enlargement of renal cysts. Clinical journal of the American Society of Nephrology: CJASN. 2010; 5(5):889–96. Epub 2010/04/03. https://doi.org/10.2215/CJN.00550110 PMID: 20360307; PubMed Central PMCID: PMCPMC2863973.
Brun M, Maugey-Laulom B, Eurin D, Didier F, Avni EF. Prenatal sonographic patterns in autosomal dominant polycystic kidney disease: a multicenter study. Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2004; 24(1):55–61. https://doi.org/10.1002/uog.1098 PMID: 15229917.
Fick-Brosnahan G, Johnson AM, Strain JD, Gabow PA. Renal asymmetry in children with autosomal dominant polycystic kidney disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 1999; 34(4):639–45. https://doi.org/10.1016/S0272-6386(99)70387-2 PMID: 10516343.
Grantham JJ. Rationale for early treatment of polycystic kidney disease. Pediatric nephrology (Berlin, Germany). 2014; 30(7):1053–62. https://doi.org/10.1007/s00467-014-2882-8 PMID: 25022529.
Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. European journal of human genetics: EJHG. 2009; 17(6):720–1. Epub 2009/03/12. https://doi.org/10.1038/ejhg.2009.26 PMID: 19277059; PubMed Central PMCID: PMCPmc2947109.
Borry P, Goffin T, Nys H, Dierickx K. Predictive genetic testing in minors for adult-onset genetic diseases. The Mount Sinai journal of medicine, New York. 2008; 75(3):287–96. https://doi.org/10.1002/msj.20038 PMID: 18704981.
Marsick R, Limwongse C, Kodish E. Genetic testing for renal diseases: medical and ethical considerations. American journal of kidney diseases: the official journal of the National Kidney Foundation. 1998; 32(6):934–45. Epub 1998/12/18. PMID: 9856508.
Golin CO, Johnson AM, Fick G, Gabow PA. Insurance for autosomal dominant polycystic kidney disease patients prior to end-stage renal disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 1996; 27(2):220–3. PMID: 8659497.
Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney international. 1992; 41(5):1311–9. PMID: 1614046.
Perrone RD, Miskulin DC. Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen? American journal of kidney diseases: the official journal of the National Kidney Foundation. 2005; 46(3):557–9. https://doi.org/10.1053/j.ajkd.2005.07.016 PMID: 16129219.
Seeman T, Dusek J, Vondrichova H, Kyncl M, John U, Misselwitz J, et al. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood pressure monitoring. 2003; 8(3):107–10. Epub 2003/08/06. https://doi.org/10.1097/01.mbp.0000085762.28312.4a PMID: 12900587.
Torres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, et al. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney international. 2017; 91(2):493–500. Epub 2016/12/21. https://doi.org/10.1016/j.kint.2016.10.018 PMID: 27993381; PubMed Central PMCID: PMCPMC5237414.
Cornec-Le Gall E, Audrezet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, et al. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology: JASN. 2015. Epub 2015/07/08. https://doi.org/10.1681/asn.2015010016 PMID: 26150605.
Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, et al. Effect of prava-statin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology: CJASN. 2014; 9(5):889–96. Epub 2014/04/12. https://doi.org/10.2215/CJN.08350813 PMID: 24721893; PubMed Central PMCID: PMCPMC4011448.
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2015. Epub 2015/03/19. https://doi.org/10.1038/ki.2015.59 PMID: 25786098.
Cadnapaphornchai MA, Masoumi A, Strain JD, McFann K, Schrier RW. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. Clinical journal of the American Society of Nephrology: CJASN. 2011; 6(2):369–76. https://doi.org/10.2215/CJN.03780410 PMID: 21115621; PubMed Central PMCID: PMC3052228.
Wuthrich RP, Kistler AD, Rodriguez D, Kapoor S, Mei C. Blood Pressure Control for Polycystic Kidney Disease. In: Li X, editor. Polycystic Kidney Disease. Brisbane (AU): Codon Publications Copyright: The Authors.; 2015.
Sans L, Pascual J, Radosevic A, Quintian C, Ble M, Molina L, et al. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients. Medicine. 2016; 95(49):e5595. Epub 2016/12/09. https://doi.org/10.1097/MD.0000000000005595 PMID: 27930582.
Chapman AB, Wei W. Imaging approaches to patients with polycystic kidney disease. Seminars in nephrology. 2011; 31(3):237–44. https://doi.org/10.1016/j.semnephrol.2011.05.003 PMID: 21784272; PubMed Central PMCID: PMC3143364.
Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. Journal of the American Society of Nephrology: JASN. 2009; 20(1):205–12. https://doi.org/10.1681/ASN.2008050507 PMID: 18945943; PubMed Central PMCID: PMC2615723.
Pei Y, Hwang YH, Conklin J, Sundsbak JL, Heyer CM, Chan W, et al. Imaging-based diagnosis of autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology: JASN. 2015; 26(3):746–53. Epub 2014/07/31. https://doi.org/10.1681/ASN.2014030297 PMID: 25074509; PubMed Central PMCID: PMCPMC4341484.
Gabow PA, Kimberling WJ, Strain JD, Manco-Johnson ML, Johnson AM. Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children. Journal of the American Society of Nephrology: JASN. 1997; 8(1):105–10. PMID: 9013454.
Reed B, Nobakht E, Dadgar S, Bekheirnia MR, Masoumi A, Belibi F, et al. Renal ultrasonographic evaluation in children at risk of autosomal dominant polycystic kidney disease. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2010; 56(1):50–6. Epub 2010/05/11. https://doi.org/10.1053/j.ajkd.2010.02.349 PMID: 20452711.
Eisenberger T, Decker C, Hiersche M, Hamann RC, Decker E, Neuber S, et al. An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease. PloS one. 2015; 10(2):e0116680. Epub 2015/02/04. https://doi.org/10.1371/journal.pone.0116680 PMID: 25646624; PubMed Central PMCID: PMCPMC4315576.
Bellone E, Mandich P, Costa P, Dalerba L, Ajmar F. Adult polycystic kidney disease: prenatal diagnosis with DNA polymorphic markers. Bollettino della Societa italiana di biologia sperimentale. 1991; 67(10–11):915–22. Epub 1991/10/01. PMID: 1821132.
Turco A, Peissel B, Quaia P, Morandi R, Bovicelli L, Pignatti PF. Prenatal diagnosis of autosomal dominant polycystic kidney disease using flanking DNA markers and the polymerase chain reaction. Prenatal diagnosis. 1992; 12(6):513–24. Epub 1992/06/01. PMID: 1355292.
De Rycke M, Georgiou I, Sermon K, Lissens W, Henderix P, Joris H, et al. PGD for autosomal dominant polycystic kidney disease type 1. Molecular human reproduction. 2005; 11(1):65–71. Epub 2004/12/14. https://doi.org/10.1093/molehr/gah128 PMID: 15591452.
LOV-2003-12-05-100 Lov om humanmedisinsk bruk av bioteknologi m.m. [Bioteknologiloven] (Act of 5 December 2003 No 100 relating to the application of biotechnology in human medicine etc.)
Boletín Oficial del Estado, No. 159 (28826–28848) (Act 14/2007 of 3 July on Biomedical Research).
LOI n 2011–814 du 7 juillet 2011 relative à la bioéthique (Bioethics Law of 2011).
Soini S. Genetic testing legislation in Western Europe-a fluctuating regulatory target. Journal of community genetics. 2012. Epub 2012/01/31. https://doi.org/10.1007/s12687-012-0078-0 PMID: 22287154; PubMed Central PMCID: PMCPMC3312949.
Gentechnikgesetz, GTG, BGBI Nr 510/1994 (The Austrian Gene Technology Act)
Bundesrat Printed Matter 374/09 April 24, 2009 Enactment of the German Federal Parliament (Bundestag) Human Genetic Examination Act (Genetic Diagnosis Act—GenDG).
Genetikai törvény (Hungarian Genetic Act of 2008): Parliamentary Act No. XXI of 2008 on the protection of human genetic data, on the human genetic studies on research and on the operation of the biobanks. Amended by Act No. CLXXVI of 2011 and by Act No. CXXVII of 2013.
Decree of the Minister of Health n°9108/97.
Lag (2006:351) om genetisk integritet m.m. Chapter 1, section 1 (Swedish Law on Genetic Integrity).
Act no. 373/2011 Coll., on Specific Health Care Services covers all genetic testing in the field of health care.
Disability Act 2005 (Number 14 of 2005).
Art. 6.725 of the Civil Code of the Republic of Lithuania.
Nys H DI, Vinck I, Dierickx K, Dequeker E, Cassiman J. Genetic Testing: Patient’s rights, insurance and employment - A survey of regulations in the European Union Luxembourg: Office for Official Publications of the European Communities2002. 148 p.
Wet van 22 augustus 2002 betreffende de rechten van de patiënt, B.S., 26 september 2002.
Turillazzi E, Frati P, Busardo FP, Gulino M, Fineschi V. The European Court legitimates access of Italian couples to assisted reproductive techniques and to pre-implantation genetic diagnosis. Medicine, science, and the law. 2015; 55(3):194–200. Epub 2014/04/30. https://doi.org/10.1177/0025802414532245 PMID: 24777348.
Harper J, Geraedts J, Borry P, Cornel MC, Dondorp WJ, Gianaroli L, et al. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. Human reproduction (Oxford, England). 2014; 29(8):1603–9. Epub 2014/07/10. https://doi.org/10.1093/humrep/deu130 PMID: 25006203.
Sujansky E, Kreutzer SB, Johnson AM, Lezotte DC, Schrier RW, Gabow PA. Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. American journal of medical genetics. 1990; 35(4):510–5. https://doi.org/10.1002/ajmg.1320350413 PMID: 2333880.
Swift O, Vilar E, Rahman B, Side L, Gale DP. Attitudes in Patients with Autosomal Dominant Polycystic Kidney Disease Toward Prenatal Diagnosis and Preimplantation Genetic Diagnosis. Genetic testing and molecular biomarkers. 2016. Epub 2016/10/01. https://doi.org/10.1089/gtmb.2016.0050 PMID: 27689416.
Zidovska J, Merta M, Kapras J. [The attitude of family members with polycystic kidney disease to the disease and presymptomatic testing]. Casopis lekaru ceskych. 1994; 133(6):184–7. PMID: 8156575.
Flahault A, Trystram D, Fouchard M, Knebelmann B, Nataf F, Joly D. Screening for Unruptured Intracra-nial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Survey of 420 Nephrologists. PloS one. 2016; 11(4):e0153176. Epub 2016/04/08. https://doi.org/10.1371/journal.pone.0153176 PMID: 27054719; PubMed Central PMCID: PMCPMC4824518.
German Society of Human Genetics. Statement on genetic diagnosis in children and adolescents. 2013 [1.8.2013].
Tuffs A. Germany allows restricted access to preimplantation genetic testing. BMJ (Clinical research ed). 2011; 343:d4425. Epub 2011/07/14. https://doi.org/10.1136/bmj.d4425 PMID: 21750080.
Benohr-Laqueur S. Fighting in the legal grey area: an analysis of the German Federal Court of Justice decision in case preimplantation genetic diagnosis. Poiesis & praxis: international journal of ethics of science and technology assessment. 2011; 8(1):3–8. Epub 2011/12/14. https://doi.org/10.1007/s10202-011-0093-y PMID: 22162961; PubMed Central PMCID: PMCPMC3218279.
Borry P, Goffin T, Nys H, Dierickx K. Attitudes regarding predictive genetic testing in minors: a survey of European clinical geneticists. American journal of medical genetics Part C, Seminars in medical genetics. 2008; 148C(1):78–83. https://doi.org/10.1002/ajmg.c.30165 PMID: 18200522.
Division UNS. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings Sept 2016.
Forum EA. Translating science into policy to improve ADPKD care. 2015.
Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G, Covic A, et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2016; 31(3):337–48. Epub 2016/02/26. https://doi.org/10.1093/ndt/gfv456 PMID: 26908832; PubMed Central PMCID: PMCPMC4762400.
Rule AD, Torres VE, Chapman AB, Grantham JJ, Guay-Woodford LM, Bae KT, et al. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. Journal of the American Society of Nephrology: JASN. 2006; 17(3):854–62. https://doi.org/10.1681/ASN.2005070697PMID: 16452494.
Bergmann C, von Bothmer J, Ortiz Bruchle N, Venghaus A, Frank V, Fehrenbach H, et al. Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. Journal of the American Society of Nephrology: JASN. 2011; 22(11):2047–56. Epub 2011/10/29. https://doi.org/10.1681/ASN.2010101080 PMID: 22034641; PubMed Central PMCID: PMCPMC3279997.
